These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 37242722)
1. Targeted Fisetin-Encapsulated β-Cyclodextrin Nanosponges for Breast Cancer. Aboushanab AR; El-Moslemany RM; El-Kamel AH; Mehanna RA; Bakr BA; Ashour AA Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242722 [TBL] [Abstract][Full Text] [Related]
2. Green self-assembled lactoferrin carboxymethyl cellulose nanogels for synergistic chemo/herbal breast cancer therapy. Atallah MA; Sallam MA; Abdelmoneem MA; Teleb M; Elkhodairy KA; Bekhit AA; Khafaga AF; Noreldin AE; Elzoghby AO; Khattab SN Colloids Surf B Biointerfaces; 2022 Sep; 217():112657. PubMed ID: 35803031 [TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid. Mady FM; Ibrahim SR Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214 [TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste. Omar SM; Ibrahim F; Ismail A Saudi Pharm J; 2020 Mar; 28(3):349-361. PubMed ID: 32194337 [TBL] [Abstract][Full Text] [Related]
5. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability. Gabr MM; Mortada SM; Sallam MA Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488 [TBL] [Abstract][Full Text] [Related]
7. Preparation and investigation of a novel combination of Shah HS; Zaib S; Khan I; Sliem MA; Alharbi O; Al-Ghorbani M; Jawad Z; Shahzadi K; Awan S Front Pharmacol; 2023; 14():1325498. PubMed ID: 38125886 [No Abstract] [Full Text] [Related]
8. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium. Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493 [TBL] [Abstract][Full Text] [Related]
9. Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting. Pawar A; Singh S; Rajalakshmi S; Shaikh K; Bothiraja C Artif Cells Nanomed Biotechnol; 2018; 46(sup1):347-361. PubMed ID: 29334247 [TBL] [Abstract][Full Text] [Related]
10. Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies. Aldawsari MF; Alhowail AH; Anwer MK; Ahmed MM Int J Nanomedicine; 2023; 18():2239-2251. PubMed ID: 37139486 [TBL] [Abstract][Full Text] [Related]
11. Preparation, Characterization, and Pharmacological Investigation of Withaferin-A Loaded Nanosponges for Cancer Therapy; In Vitro, In Vivo and Molecular Docking Studies. Shah HS; Nasrullah U; Zaib S; Usman F; Khan A; Gohar UF; Uddin J; Khan I; Al-Harrasi A Molecules; 2021 Nov; 26(22):. PubMed ID: 34834081 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511 [TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. Ansari KA; Vavia PR; Trotta F; Cavalli R AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574 [TBL] [Abstract][Full Text] [Related]
14. Formulation Optimization and Biopharmaceutical Evaluation of Imatinib Mesylate Loaded β-cyclodextrin Nanosponges. Kamble M; Zaheer Z; Mokale S; Zainuddin R Pharm Nanotechnol; 2019; 7(5):343-361. PubMed ID: 31549599 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of EDTA Dianhydride Versus Diphenyl Carbonate Nanosponges for Curcumin. Mashaqbeh H; Obaidat R; Al-Shar'i NA AAPS PharmSciTech; 2022 Aug; 23(7):229. PubMed ID: 35974237 [TBL] [Abstract][Full Text] [Related]
16. Nanosponges-based Drug Delivery System for the Cosmeceutical Applications of Stabilized Ascorbic Acid. Zuberi SA; Sheraz MA; Ali SA; Shah MR; Mujahid S; Ahmed S; Anwar Z Curr Drug Deliv; 2023; 20(10):1504-1524. PubMed ID: 35975853 [TBL] [Abstract][Full Text] [Related]
17. Preparation and Evaluation of Diosmin-Loaded Diphenylcarbonate-Cross-Linked Cyclodextrin Nanosponges for Breast Cancer Therapy. Anwer MK; Ahmed MM; Aldawsari MF; Iqbal M; Kumar V Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678517 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Characterization of Carboxymethyl Chitosan Nanosponges with Cyclodextrin Blends for Drug Solubility Improvement. Rizvi SSB; Akhtar N; Minhas MU; Mahmood A; Khan KU Gels; 2022 Jan; 8(1):. PubMed ID: 35049590 [TBL] [Abstract][Full Text] [Related]
19. Formulation, Characterization, Anti-Inflammatory and Cytotoxicity Study of Sesamol-Laden Nanosponges. Nair AB; Dalal P; Kadian V; Kumar S; Kapoor A; Garg M; Rao R; Aldhubiab B; Sreeharsha N; Almuqbil RM; Attimarad M; Elsewedy HS; Shinu P Nanomaterials (Basel); 2022 Nov; 12(23):. PubMed ID: 36500833 [TBL] [Abstract][Full Text] [Related]
20. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation. Mashaqbeh H; Obaidat R; Al-Shar'i N Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]